Blockbuster Deal Creates Buying Opportunity
Equipping the Biopharma Revolution
Cleaning Up
Home of the Small Deal
Big Pharma: Buy the Dips
Although some of our best-performing stocks have come from cyclical sectors that benefit from the recovering global economy, every long-term portfolio should have some exposure to Big Pharma.
Big Pharma: Good for What Ails Your Portfolio
The largest global pharmaceutical companies have earned a reputation for resilience over the years. But investors shouldn’t overlook Big Pharma’s emerging growth story.
Best in Show: A Stock for the Dogs (and Cats)
Although uncertainty reigns supreme in the human health care market, companies that focus on health products and services for pets and livestock continue to prosper--and this stock is top dog.
Healthy Returns
Shares of health insurers trade at favorable valuations because of concerns that the implementation of the Affordable Care Act will weigh on the industry's profit margins. These risks are real but overstated, giving intrepid investors a solid buying opportunity.
DISCLAIMER: Capitalist Times, LLC is a publisher of financial news and opinions and NOT a securities broker/dealer or an investment advisor. You are responsible for your own investment decisions. All information contained in our newsletters or on our website(s) should be independently verified with the companies mentioned, and readers should always conduct their own research and due diligence and consider obtaining professional advice before making any investment decision. As a condition to accessing Capitalist Times materials and websites, you agree to our Terms and Conditions of Use, available here including without limitation all disclaimers of warranties and limitations on liability contained therein. Owners, employees and writers may hold positions in the securities that are discussed in our newsletters or on our website.
© Copyright 2020 Capitalist Times, LLC. All rights reserved.